Should I stay or should I go? A qualitative study exploring participation in a urology clinical trial.

Autor: Lie MLS; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.; School of Geography, Politics and Sociology, Newcastle University, Newcastle upon Tyne, UK., Lecouturier J; Institute of Health & Society, Newcastle University, Newcastle upon Tyne, UK., Harding C; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. chris.harding@nuth.nhs.uk.; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. chris.harding@nuth.nhs.uk.; Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne, NE7 7DN, UK. chris.harding@nuth.nhs.uk.
Jazyk: angličtina
Zdroj: International urogynecology journal [Int Urogynecol J] 2019 Jan; Vol. 30 (1), pp. 9-16. Date of Electronic Publication: 2018 Oct 17.
DOI: 10.1007/s00192-018-3784-2
Abstrakt: Introduction and Hypothesis: The aim of this study was to identify modifiable factors to improve recruitment in a urology clinical trial of women with recurrent urinary tract infection (rUTI). An embedded qualitative study was conducted with patients and recruiting clinicians in the first 8 months of the trial. We present a matrix of factors influencing how patients make decisions about trial participation.
Methods: This was a qualitative study using telephone interviews. When they were first approached about the trial, women were asked to complete an expression of interest form if they wished to be contacted for an interview. Data were analysed thematically. NVivo 10 software (Qualitative data analysis software. 10th ed: QSR International Pty Ltd; 2012) was used as a management tool.
Results: Thirty patients and 11 clinicians were interviewed. Influences on patient participation included the impact of rUTI on quality of life (QoL), understanding of antibiotic resistance, and previous experiences with antibiotics either positive or negative. Very few women who declined the trial agreed to be interviewed. However, some of those who participated had reservations about it. These included the perceived risk of trying a new treatment, trial length, and the burden of participating. One person interviewed left the trial because of repeated infections and difficulties getting general practitioner appointments.
Conclusions: A combination of factors worked to influence women to decide to participate, to remain in, or to leave the trial. A better understanding of how these factors interact and work can assist in the recruitment and retention of individual trial participants.
Databáze: MEDLINE
Externí odkaz: